Artificial intelligence empowering rare diseases: a bibliometric perspective over the last two decades

被引:2
作者
Ou, Peiling [1 ]
Wen, Ru [1 ]
Shi, Linfeng [1 ]
Wang, Jian [1 ]
Liu, Chen [1 ]
机构
[1] Army Med Univ, Mil Med Univ 3, Southwest Hosp, Magnet Resonance Imaging Translat Med Ctr 7T,Dept, 30 Gao Tan Yan St, Chongqing 400038, Peoples R China
基金
中国国家自然科学基金;
关键词
Rare diseases; Artificial intelligence; Bibliometric analysis; Medical informatics; WEB;
D O I
10.1186/s13023-024-03352-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
ObjectiveTo conduct a comprehensive bibliometric analysis of the application of artificial intelligence (AI) in Rare diseases (RDs), with a focus on analyzing publication output, identifying leading contributors by country, assessing the extent of international collaboration, tracking the emergence of research hotspots, and detecting trends through keyword bursts.MethodsIn this bibliometric study, we identified and retrieved publications on AI applications in RDs spanning 2003 to 2023 from the Web of Science (WoS). We conducted a global research landscape analysis and utilized CiteSpace to perform keyword clustering and burst detection in this field.ResultsA total of 1501 publications were included in this study. The evolution of AI applications in RDs progressed through three stages: the start-up period (2003-2010), the steady development period (2011-2018), and the accelerated growth period (2019-2023), reflecting this field's increasing importance and impact at the time of the study. These studies originated from 85 countries, with the United States as the leading contributor. "Mutation", "Diagnosis", and "Management" were the top three keywords with high frequency. Keyword clustering analysis identified gene identification, effective management, and personalized treatment as three primary research areas of AI applications in RDs. Furthermore, the keyword burst detection indicated a growing interest in the areas of "biomarker", "predictive model", and "data mining", highlighting their potential to shape future research directions.ConclusionsOver two decades, research on the AI applications in RDs has made remarkable progress and shown promising results in the development. Advancing international transboundary cooperation is essential moving forward. Utilizing AI will play a more crucial role across the spectrum of RDs management, encompassing rapid diagnosis, personalized treatment, drug development, data integration and sharing, and continuous monitoring and care.
引用
收藏
页数:10
相关论文
共 49 条
[21]   Identifying facial phenotypes of genetic disorders using deep learning [J].
Gurovich, Yaron ;
Hanani, Yair ;
Bar, Omri ;
Nadav, Guy ;
Fleischer, Nicole ;
Gelbman, Dekel ;
Basel-Salmon, Lina ;
Krawitz, Peter M. ;
Kamphausen, Susanne B. ;
Zenker, Martin ;
Bird, Lynne M. ;
Gripp, Karen W. .
NATURE MEDICINE, 2019, 25 (01) :60-+
[22]   Personalized Medicine: What's in it for Rare Diseases? [J].
Halfmann, Sebastian Schee Genannt ;
Mahlmann, Laura ;
Leyens, Lada ;
Reumann, Matthias ;
Brand, Angela .
RARE DISEASES EPIDEMIOLOGY: UPDATE AND OVERVIEW, 2ND EDITION, 2017, 1031 :387-404
[23]   Negotiating prices of drugs for rare diseases [J].
Henrard, Severine ;
Arickx, Francis .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2016, 94 (10) :779-781
[24]   Understanding the factors influencing acceptability of AI in medical imaging domains among healthcare professionals: A scoping review [J].
Hua, David ;
Petrina, Neysa ;
Young, Noel ;
Cho, Jin-Gun ;
Poon, Simon K. .
ARTIFICIAL INTELLIGENCE IN MEDICINE, 2024, 147
[25]   Bibliometric Analysis of Functional Magnetic Resonance Imaging Studies on Acupuncture Analgesia Over the Past 20 Years [J].
Huang, Liuyang ;
Xu, Guixing ;
He, Jiamei ;
Tian, Hao ;
Zhou, Zhuo ;
Huang, Fengyuan ;
Liu, Yilin ;
Sun, Mingsheng ;
Liang, Fanrong .
JOURNAL OF PAIN RESEARCH, 2021, 14 :3773-3789
[26]   Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance [J].
Izquierdo-Garcia, Elsa ;
Lazaro-Cebas, Andrea ;
Pastor, Berta Montero ;
Diaz, Ana Such ;
Alvaro-Alonso, Elena Alba ;
Guerra, Laura Lopez ;
Escobar-Rodriguez, Ismael .
ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
[27]   Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis [J].
Jin, Hongxia ;
Lu, Lu ;
Fan, Haojun .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (06)
[28]   Precision Medicine, AI, and the Future of Personalized Health Care [J].
Johnson, Kevin B. ;
Wei, Wei-Qi ;
Weeraratne, Dilhan ;
Frisse, Mark E. ;
Misulis, Karl ;
Rhee, Kyu ;
Zhao, Juan ;
Snowdon, Jane L. .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01) :86-93
[29]   The importance of international collaboration for rare diseases research: a European perspective [J].
Julkowska, D. ;
Austin, C. P. ;
Cutillo, C. M. ;
Gancberg, D. ;
Hager, C. ;
Halftermeyer, J. ;
Jonker, A. H. ;
Lau, L. P. L. ;
Norstedt, I. ;
Rath, A. ;
Schuster, R. ;
Simelyte, E. ;
van Weely, S. .
GENE THERAPY, 2017, 24 (09) :562-571
[30]   Using Artificial Intelligence to Detect COVID-19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy [J].
Li, Lin ;
Qin, Lixin ;
Xu, Zeguo ;
Yin, Youbing ;
Wang, Xin ;
Kong, Bin ;
Bai, Junjie ;
Lu, Yi ;
Fang, Zhenghan ;
Song, Qi ;
Cao, Kunlin ;
Liu, Daliang ;
Wang, Guisheng ;
Xu, Qizhong ;
Fang, Xisheng ;
Zhang, Shiqin ;
Xia, Juan ;
Xia, Jun .
RADIOLOGY, 2020, 296 (02) :E65-+